• News
  • SAN DIEGO
  • Medical

Amgen, Illumina team on personalized medicine test

Biotech drugmaker Amgen and Illumina, a maker of genetic testing equipment, said Wednesday they are developing a test that will identify patients who might be helped by Amgen's colon cancer drug Vectibix.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
191.16
  -1.86  
- 0.96%
1,083,169,000
213.33
128.38

Insider Trade Data

Date Insider Shares Type Value
04/15/2015 Henry, Christian O 3,751 Sell $709,020
04/15/2015 Naclerio, Nicholas J 6,590 Sell $1,245,812
04/13/2015 Stapley, Marc A 3,000 Sell $570,373
04/13/2015 Stapley, Marc A 2,400 Exchange $87,120
04/10/2015 Epstein, Robert S 2,000 Exchange $102,340

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
Subscribe Today!